FDA Orange Book · active-ingredient family
Amino acids; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride
Amino acids; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride is approved in 3 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:TRAVASOL 5.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER · NDA 020173
3
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| TRAVASOL 5.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER×2 | BAXTER HLTHCARE | NDA 020173 | — | Oct 27, 1995 | |
| TRAVASOL 3.5% SULFITE FREE W/ ELECTROLYTES IN PLASTIC CONTAINER | BAXTER HLTHCARE | NDA 020177 | — | Oct 23, 1995 | |
| TRAVASOL 3.5% W/ ELECTROLYTES×3 | BAXTER HLTHCARE | NDA 017493 | — | Approved Prior to Jan 1, 1982 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Amino acids; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
